
AesculaTech YC 申请
AesculaTech 在 Winter 2018 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。
- YC 批次
- Winter 2018
- 行业
- HealthcareMedical Devices
- 团队规模
- 6
- 状态
- Active
- 已发布
- 2017
创始人
Niki BayatFounder/CEO
AesculaTech 做什么
AesculaTech believes in building better lives through smart chemistry. We design custom smart materials for a range of biomedical, commercial, and industrial applications. Our platform technology, AesculaGel offers adaptive response to a wide range of stimuli and can be tailor-made for biocompatibility, material strength, and a range of other attributes. Founded by one of MIT's 35 under 35 Innovators, AesculaTech is the shared vision of scientists, engineers, and medical experts. Our cornerstone product, Humidifeye, is an ophthalmic platform to treat dry eye disease. Dry eye affects more than 25 million Americans and the global treatment market is projected higher than $6 Billion within the next decade. Our thermally responsive, form-fitting materials are suitable for sustained yet reversible occlusion across a range of treatment times. In contrast to existing technologies, our product will not extrude, or cause discomfort as it adapts to patients. Though Humidifeye is not yet FDA approved, expect to hear about it soon! In coordination with partners across several sectors, we have a variety of groundbreaking technologies in the works that live up to our vision. This work has already been recognized. AesculaTech was named a Rosenman Innovator, received a National Science Foundation I-Corps grant, was a finalist in the 2019 Octane High Tech Awards, and is a graduate of both the Y Combinator and TMCx accelerator programs. In short, Y-Combinator was only the beginning.
AesculaTech 的 YC 申请,重建版
Y Combinator 申请
AesculaTech,Winter 2018 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
AesculaTech
Responsive materials, better lives.
We make AesculaGel, a smart, adaptive material platform that responds to stimuli and can be tailor-made for strength and biocompatibility. Our lead product, Humidifeye, uses these materials for sustained, comfortable treatment of dry eye disease by providing thermally responsive, form-fitting occlusion that adapts to patients instead of causing discomfort or extrusion like current options.
We live in Los Angeles, CA, and we would continue to be based here after YC.
Los Angeles is our home base with access to local medical experts and manufacturing partners. Staying here keeps our team close and connected to the relevant biomedical ecosystem.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。
常见问题解答
这是 AesculaTech 的真实 YC 申请吗?
不是。Y Combinator 对提交的申请保密。这是重建版:使用 AesculaTech 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 AesculaTech 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。
AesculaTech 是哪个 YC 批次的?
AesculaTech 是 Y Combinator Winter 2018 批次的成员。
谁创立了 AesculaTech?
AesculaTech 由 Niki Bayat 创立。
AesculaTech 做什么?
Responsive materials, better lives.
如何阅读完整的重建申请?
创建免费的 Round Funded 账户。YC Insights 中包含 AesculaTech 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。